Atezolizumab in Combination With Bevacizumab and Chemotherapy Versus Bevacizumab and Chemotherapy in Recurrent Ovarian Cancer - a Randomized Phase III Trial
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Doxorubicin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 01 Feb 2018 Planned initiation date changed from 1 Feb 2018 to 1 Apr 2018.
- 08 Jan 2018 Planned initiation date changed from 1 Jan 2018 to 1 Feb 2018.
- 29 Nov 2017 New trial record